{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:38:56Z","timestamp":1790872736802,"version":"4.1.0"},"reference-count":44,"publisher":"American Society of Hematology","issue":"13","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,7,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Severe chronic neutropenia (SCN), defined as blood neutrophils &amp;lt;0.5 \u00d7 109\/L for &amp;gt;3 months, is an uncommon hematological condition associated with recurrent and severe bacterial infections. After short-term clinical trials showed the benefits of granulocyte colony-stimulating factor (G-CSF) treatment for SCN, SCNIR (Severe Chronic Neutropenia International Registry) opened to determine the long-term benefits and safety of this treatment. This report summarizes findings from more than 16 000 patient-years of prospective observations for patients with congenital and acquired SCN. We observed that adverse outcomes depend on the underlying etiology. Myelodysplasia (MDS) and acute myeloid leukemia (AML) occur infrequently and largely in patients with congenital neutropenias. Having cyclic or chronic autoimmune\/ idiopathic neutropenia portends a favorable prognosis. A few patients with idiopathic neutropenia evolve to develop lymphoid malignancies, but they do not appear to be at increased risk of myeloid malignancies, even with very long-term G-CSF therapy. Progression to systemic autoimmune diseases, bone marrow (BM) failure, aplastic anemia, or nonmyeloid malignancies are not expected consequences of SCN or treatment with G-CSF.<\/jats:p>","DOI":"10.1182\/bloodadvances.2021005684","type":"journal-article","created":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T14:13:51Z","timestamp":1651068831000},"page":"3861-3869","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":23,"title":["Outcomes for patients with severe chronic neutropenia treated with granulocyte colony-stimulating factor"],"prefix":"10.1182","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7146-1440","authenticated-orcid":false,"given":"David C.","family":"Dale","sequence":"first","affiliation":[{"name":"1Department of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey Anna","family":"Bolyard","sequence":"additional","affiliation":[{"name":"2Severe Chronic Neutropenia International Registry, University of Washington, Seattle, WA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"IV","given":"James A.","family":"Shannon","sequence":"additional","affiliation":[{"name":"2Severe Chronic Neutropenia International Registry, University of Washington, Seattle, WA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7223-375X","authenticated-orcid":false,"given":"James A.","family":"Connelly","sequence":"additional","affiliation":[{"name":"3Division of Hematology-Oncology, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel C.","family":"Link","sequence":"additional","affiliation":[{"name":"4Section of Stem Cell Biology, Division of Oncology, Washington University School of Medicine, St. Louis, MO;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Ann","family":"Bonilla","sequence":"additional","affiliation":[{"name":"5Pediatric Hematology\/Oncology, St. Joseph\u2019s Children\u2019s Hospital, Paterson, NJ; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter E.","family":"Newburger","sequence":"additional","affiliation":[{"name":"6Department of Pediatrics, University of Massachusetts Medical School, Worcester, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2022,7,1]]},"reference":[{"key":"2022070115214526200_B1","first-page":"1021","volume-title":"Williams Hematology","author":"Dale","year":"2021","edition":"10th ed."},{"issue":"10","key":"2022070115214526200_B2","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1182\/blood.V81.10.2496.2496","article-title":"A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia","volume":"81","author":"Dale","year":"1993","journal-title":"Blood."},{"issue":"2","key":"2022070115214526200_B3","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/ajh.10255","article-title":"Severe chronic neutropenia: treatment and follow-up of patients in the Severe Chronic Neutropenia International Registry","volume":"72","author":"Dale","year":"2003","journal-title":"Am J Hematol."},{"issue":"2","key":"2022070115214526200_B4","first-page":"429","article-title":"Myelodysplasia syndrome and acute myeloid leukemia in patients with congenital neutropenia receiving G-CSF therapy","volume":"96","author":"Freedman","year":"2000","journal-title":"Blood."},{"issue":"2","key":"2022070115214526200_B5","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2141.2007.06897.x","article-title":"Neutrophil elastase mutations and risk of leukaemia in severe congenital neutropenia","volume":"140","author":"Rosenberg","year":"2008","journal-title":"Br J Haematol."},{"issue":"2","key":"2022070115214526200_B6","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1365-2141.2010.08216.x","article-title":"Stable long-term risk of leukaemia in patients with severe congenital neutropenia maintained on G-CSF therapy","volume":"150","author":"Rosenberg","year":"2010","journal-title":"Br J Haematol."},{"issue":"1","key":"2022070115214526200_B7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/MOH.0000000000000105","article-title":"The diversity of mutations and clinical outcomes for ELANE-associated neutropenia","volume":"22","author":"Makaryan","year":"2015","journal-title":"Curr Opin Hematol."},{"issue":"23","key":"2022070115214526200_B8","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1056\/NEJMc1709258","article-title":"Long-term effects of G-CSF therapy in cyclic neutropenia","volume":"377","author":"Dale","year":"2017","journal-title":"N Engl J Med."},{"issue":"1","key":"2022070115214526200_B9","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/MOH.0000000000000305","article-title":"An update on the diagnosis and treatment of chronic idiopathic neutropenia","volume":"24","author":"Dale","year":"2017","journal-title":"Curr Opin Hematol."},{"issue":"1","key":"2022070115214526200_B10","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1182\/asheducation-2016.1.38","article-title":"Autoimmune and other acquired neutropenias","volume":"2016","author":"Newburger","year":"2016","journal-title":"Hematology (Am Soc Hematol Educ Program)."},{"issue":"1","key":"2022070115214526200_B11","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/MOH.0000000000000474","article-title":"Neutropenia in glycogen storage disease Ib: outcomes for patients treated with granulocyte colony-stimulating factor","volume":"26","author":"Dale","year":"2019","journal-title":"Curr Opin Hematol."},{"issue":"11","key":"2022070115214526200_B12","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1182\/blood.V106.11.385.385","article-title":"Antineutrophil antibodies lead to mistaken identity in severe congenital neutropenia","volume":"106","author":"Boxer","year":"2005","journal-title":"Blood."},{"key":"2022070115214526200_B13","author":"Dale"},{"issue":"3","key":"2022070115214526200_B14","doi-asserted-by":"crossref","first-page":"17032","DOI":"10.1038\/nrdp.2017.32","article-title":"Severe congenital neutropenias","volume":"3","author":"Skokowa","year":"2017","journal-title":"Nat Rev Dis Primers."},{"issue":"7","key":"2022070115214526200_B15","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1182\/blood.V96.7.2317","article-title":"Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia","volume":"96","author":"Dale","year":"2000","journal-title":"Blood."},{"issue":"10","key":"2022070115214526200_B16","doi-asserted-by":"crossref","first-page":"e27923","DOI":"10.1002\/pbc.27923","article-title":"Homozygous c.130-131 ins A (pW44X) mutation in the HAX1 gene as the most common cause of congenital neutropenia in Turkey: report from the Turkish Severe Congenital Neutropenia Registry","volume":"66","author":"Y\u0131lmaz Karap\u0131nar","year":"2019","journal-title":"Pediatr Blood Cancer."},{"issue":"3","key":"2022070115214526200_B17","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/ajh.25374","article-title":"Neutropenia in the age of genetic testing: advances and challenges","volume":"94","author":"Furutani","year":"2019","journal-title":"Am J Hematol"},{"issue":"1","key":"2022070115214526200_B18","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/sj.bmt.1704718","article-title":"Hematopoietic stem cell transplantation in severe congenital neutropenia: experience of the French SCN register","volume":"35","author":"Ferry","year":"2005","journal-title":"Bone Marrow Transplant."},{"issue":"16","key":"2022070115214526200_B19","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1182\/blood-2015-02-628859","article-title":"Stem cell transplantation in severe congenital neutropenia: an analysis from the European Society for Blood and Marrow Transplantation","volume":"126","author":"Fioredda","year":"2015","journal-title":"Blood."},{"issue":"8","key":"2022070115214526200_B20","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1038\/s41409-020-0800-1","article-title":"HSCT may lower leukemia risk in ELANE neutropenia: a before-after study from the French Severe Congenital Neutropenia Registry","volume":"55","author":"Rotulo","year":"2020","journal-title":"Bone Marrow Transplant."},{"issue":"2","key":"2022070115214526200_B21","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/00005792-197903000-00002","article-title":"Chronic neutropenia","volume":"58","author":"Dale","year":"1979","journal-title":"Medicine (Baltimore)."},{"issue":"3","key":"2022070115214526200_B22","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1182\/blood.V54.3.581.581","article-title":"Neutrophil kinetics in chronic neutropenia","volume":"54","author":"Price","year":"1979","journal-title":"Blood."},{"issue":"12","key":"2022070115214526200_B23","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1080\/10428194.2017.1324154","article-title":"Cytotoxic T cells in chronic idiopathic neutropenia express restricted antigen receptors","volume":"58","author":"Mastrodemou","year":"2017","journal-title":"Leuk Lymphoma."},{"issue":"9","key":"2022070115214526200_B24","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1182\/blood.V84.9.2923.2923","article-title":"Effects of in\u00a0vivo recombinant methionyl human granulocyte colony-stimulating factor on the neutrophil response and peripheral blood colony-forming cells in healthy young and elderly adult volunteers","volume":"84","author":"Chatta","year":"1994","journal-title":"Blood."},{"issue":"1","key":"2022070115214526200_B25","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1182\/blood.V88.1.335.335","article-title":"Effect of recombinant granulocyte colony-stimulating factor on neutrophil kinetics in normal young and elderly humans","volume":"88","author":"Price","year":"1996","journal-title":"Blood."},{"issue":"5","key":"2022070115214526200_B26","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.4049\/jimmunol.1502690","article-title":"Changes in gene expression during G-CSF-induced emergency granulopoiesis in humans","volume":"197","author":"Pedersen","year":"2016","journal-title":"J Immunol."},{"issue":"9","key":"2022070115214526200_B27","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1001\/jama.270.9.1132","article-title":"Quality of life of patients with severe chronic neutropenia receiving long-term treatment with granulocyte colony-stimulating factor","volume":"270","author":"Jones","year":"1993","journal-title":"JAMA."},{"issue":"5","key":"2022070115214526200_B28","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s12185-021-03089-8","article-title":"Quality of life and patient-reported outcomes in chronic severe neutropenia conditions","volume":"113","author":"Michniacki","year":"2021","journal-title":"Int J Hematol."},{"issue":"14","key":"2022070115214526200_B29","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1182\/blood-2015-03-634493","article-title":"Severe chronic primary neutropenia in adults: report on a series of 108 patients","volume":"126","author":"Sicre de Fontbrune","year":"2015","journal-title":"Blood."},{"issue":"4","key":"2022070115214526200_B30","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jfma.2010.12.003","article-title":"Clinical manifestations and outcomes of pediatric chronic neutropenia","volume":"111","author":"Wan","year":"2012","journal-title":"J Formos Med Assoc."},{"issue":"21","key":"2022070115214526200_B31","doi-asserted-by":"crossref","first-page":"7492","DOI":"10.1074\/jbc.RA120.012366","article-title":"Inducible expression of a disease-associated ELANE mutation impairs granulocytic differentiation, without eliciting an unfolded protein response","volume":"295","author":"Garg","year":"2020","journal-title":"J Biol Chem."},{"issue":"1","key":"2022070115214526200_B32","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/MOH.0000000000000479","article-title":"Mechanisms of leukemic transformation in congenital neutropenia","volume":"26","author":"Link","year":"2019","journal-title":"Curr Opin Hematol."},{"issue":"5","key":"2022070115214526200_B33","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.stem.2021.03.023","article-title":"iPSC modeling of stage-specific leukemogenesis reveals BAALC as a key oncogene in severe congenital neutropenia","volume":"28","author":"Dannenmann","year":"2021","journal-title":"Cell Stem Cell."},{"issue":"1","key":"2022070115214526200_B34","first-page":"45","article-title":"Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia","volume":"90","author":"Donadieu","year":"2005","journal-title":"Haematologica."},{"issue":"8","key":"2022070115214526200_B35","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.ejim.2015.05.019","article-title":"Is chronic neutropenia always a benign disease? Evidences from a 5-year prospective study","volume":"26","author":"Fattizzo","year":"2015","journal-title":"Eur J Intern Med."},{"issue":"1","key":"2022070115214526200_B36","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1182\/asheducation-2017.1.181","article-title":"Chronic neutropenia in LGL leukemia and rheumatoid arthritis","volume":"2017","author":"Gazitt","year":"2017","journal-title":"Hematology (Am Soc Hematol Educ Program)."},{"issue":"3","key":"2022070115214526200_B37","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.exphem.2007.11.011","article-title":"Clonal predominance of CD8(+) T cells in patients with unexplained neutropenia","volume":"36","author":"Wlodarski","year":"2008","journal-title":"Exp Hematol."},{"issue":"2","key":"2022070115214526200_B38","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3324\/haematol.2017.175729","article-title":"Somatic STAT3 mutations in Felty syndrome: an implication for a common pathogenesis with large granular lymphocyte leukemia","volume":"103","author":"Savola","year":"2018","journal-title":"Haematologica."},{"issue":"3","key":"2022070115214526200_B39","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3109\/07853890.2014.882105","article-title":"Uncovering the pathogenesis of large granular lymphocytic leukemia-novel STAT3 and STAT5b mutations","volume":"46","author":"Rajala","year":"2014","journal-title":"Ann Med."},{"issue":"1","key":"2022070115214526200_B40","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/s13075-018-1760-3","article-title":"The risks of cancer development in systemic lupus erythematosus (SLE) patients: a systematic review and meta-analysis","volume":"20","author":"Song","year":"2018","journal-title":"Arthritis Res Ther."},{"issue":"10","key":"2022070115214526200_B41","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1177\/2050640618800540","article-title":"Risks for lymphoma and gastrointestinal carcinoma in patients with newly diagnosed adult-onset celiac disease: consequences for follow-up: celiac disease, lymphoma and GI carcinoma","volume":"6","author":"van Gils","year":"2018","journal-title":"United European Gastroenterol J."},{"key":"2022070115214526200_B42","doi-asserted-by":"crossref","first-page":"777","DOI":"10.3389\/fimmu.2019.00777","article-title":"A systematic review on predisposition to lymphoid (B and T cell) neoplasias in patients with primary immunodeficiencies and immune dysregulatory disorders (inborn errors of immunity)","volume":"10","author":"Riaz","year":"2019","journal-title":"Front Immunol."},{"issue":"22","key":"2022070115214526200_B43","doi-asserted-by":"crossref","first-page":"5644","DOI":"10.1182\/bloodadvances.2020002793","article-title":"Late-onset and long-lasting autoimmune neutropenia: an analysis from the Italian Neutropenia Registry","volume":"4","author":"Fioredda","year":"2020","journal-title":"Blood Adv."},{"issue":"1","key":"2022070115214526200_B44","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/MOH.0000000000000558","article-title":"Registries for study of nonmalignant hematological diseases: the example of the Severe Chronic Neutropenia International Registry","volume":"27","author":"Dale","year":"2020","journal-title":"Curr Opin Hematol."}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/13\/3861\/1904955\/advancesadv2021005684.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/13\/3861\/1904955\/advancesadv2021005684.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T18:48:28Z","timestamp":1700506108000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/6\/13\/3861\/485070\/Outcomes-for-patients-with-severe-chronic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,1]]},"references-count":44,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2022,7,12]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2021005684","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,1]]}}}